This hypermethylation aligns with existing literature, which suggests that the inactivation of tumor suppressors, such as RASSF1A, often occurs early during carcinogenesis, rather than as a late event, in several cancers such as renal tumors [52]. Here, RASSF1 is linked to kidney neoplasm.